MONOCLONAL ANTIBODY SPECIFIC TO FULL-LENGTH FREE AIM AND USE THEREOF

Title:

MONOCLONAL ANTIBODY SPECIFIC TO FULL-LENGTH FREE AIM AND USE THEREOF

Document Type and Number:

Japanese Patent JP2023146558

Kind Code:

A

Abstract:

To provide a monoclonal antibody that binds to only a specific form of AIM, and an immunological analysis method for full-length free AIM in a sample using the monoclonal antibody.SOLUTION: The inventors have succeeded in recognizing the SRCR3 domain of AIM, preparing a monoclonal antibody specific to full-length free AIM, and using the monoclonal antibody to immunologically analyze the full-length free AIM in a sample.SELECTED DRAWING: None

Inventors:

MIYAZAKI TORU
ASAO MAYU
MURAKAMI YUSUKE

Application Number:

JP2022053788A

Publication Date:

October 12, 2023

Filing Date:

March 29, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

EIKEN CHEMICAL
MIYAZAKI TORU

International Classes:

C07K16/18; A61K39/395; A61P1/16; A61P3/04; A61P13/12; A61P25/00; A61P29/00; A61P31/10; A61P35/00; A61P43/00; C07K17/00; C12P21/08; G01N33/53

Attorney, Agent or Firm:

Patent Attorney Corporation St. Crest International Patent Office

Previous Patent: Sheet conveyance device and image forming device

Next Patent: Information processing device, information processing method, and program